Lead the 1000 person GBO organization to shape and propel our US Commercial, Medical and Government Affairs (CMG) business with industry-leading functional capabilities and operational excellence. GBO comprises centers of excellence in digital, omnichannel, and customer experience; advanced analytics, data science, and AI; patient support services; and learning & skill development. Executive Leadership Team member driving the strategy, operations, and effectiveness of a 35-product, $27 billion business. Architect and leader of multi-year agile, ecosystem, and digital transformation of entire US business to successfully navigate dramatic market and portfolio shifts. This holistic change in our go-to-market model has fueled significant growth in revenue, profitability, and overall return on investment in the US business.

Led Genentech Immunology & Ophthamology (1) pipeline strategy, business development, and commercial activities from lifecycle investment decisions through early launch preparation; (2) access and distribution excellence for the business unit, and (3) a national field team delivering business to business interactions with key national accounts to ensure appropriate pull through of brand strategies.

Led the 230 member department comprised of Competitive Intelligence, Forecasting & Business Analysis, Industry Analytics, Market Planning, and Marketing Science. MA&S provides strategic recommendations, market insights, forecasting, and advanced data analysis to guide key decision makers on brand strategy, sales targeting and promotional effectiveness, lifecycle investments, financial target setting, and portfolio planning. Member, then leader, of oncology pipeline Market Planning 2005-2008. Leader of oncology Market Planning 2008-2010. Leader of Market Planning 2011-2012.

Senior Manager, Indiplon, 2003 – 2005: Guided global brand development and launch planning of an anti-insomnia medication through customer and market insights. Core member of brand team, leader of market analytics sub-team. Manager, New Product Development, 2001 – 2003: Provided strategic counsel and market insights to guide global development and positioning of discovered and in-licensed neuroscience and anti-infective molecules. Global core team member.

TWO-WAY WIRELESS SYSTEMS MARKETING: Analyzed business-to-business market for two-way radio systems to improve sales effectiveness and guide product development and marketing efforts. Designed & implemented customer satisfaction survey and segmented customer base to identify key product and service features driving purchase

Developed tailored client solutions in healthcare and other industries. Led and facilitated teams, managed projects, and performed extensive quantitative and qualitative analyses. Clients included pharmaceutical manufacturers, health plans, hospital systems, and state government.

BUREAU OF ECONOMIC AND BUSINESS AFFAIRS: Led State interaction with U.S. agencies, embassies and Congress on behalf of citizens involved in investment disputes abroad. Facilitated negotiations between U.S. and foreign governments.